泰国医疗行业应投资于肽研究并放宽肽在临床应用中的规定限制

Thailand Medical

泰国医学

: Thailand’s medical sector is approaching a defining moment as peptide-based therapeutics rapidly reshape global healthcare. Once considered niche tools of experimental biology, peptides are now driving breakthroughs across chronic disease management, regenerative medicine, and wellness science. As global demand surges, Thailand is uniquely positioned to capitalize on this shift, but doing so will require decisive investment in research, enhanced physician training, and regulatory evolution that balances safety with accessibility..

：泰国医疗行业正迎来一个决定性的时刻，因为基于肽的疗法正在迅速重塑全球医疗保健。肽曾经被视为实验生物学的小众工具，如今却在慢性病管理、再生医学和健康科学领域推动突破。随着全球需求激增，泰国在利用这一转变方面具有独特的优势，但要做到这一点，需要在研究方面进行果断投资，加强医生培训，并推动在安全性和可及性之间取得平衡的监管改革。

Peptides are rapidly transforming healthcare and positioning Thailand as a future global leader in advanced medical innovation

肽正在迅速改变医疗保健，并将泰国定位为未来全球先进的医疗创新领导者。

Peptides, short chains of amino acids that act as signaling molecules within the body, are proving to be one of the most versatile and targeted therapeutic classes in modern medicine. Unlike conventional pharmaceuticals, peptides can mimic natural biological processes with remarkable precision. This allows for highly specific interventions that minimize side effects while maximizing therapeutic outcomes.

肽是氨基酸的短链，作为体内信号分子，它们被证明是现代医学中最通用且具有靶向性的治疗类别之一。与传统药物不同，肽能够以极高的精确度模拟自然生物过程。这使得干预措施高度特异，在最大化治疗效果的同时将副作用降至最低。

As a result, peptides are increasingly used to treat complex diseases ranging from metabolic disorders to cancer and neurodegenerative conditions..

因此，肽类药物越来越多地用于治疗从代谢紊乱到癌症和神经退行性疾病等复杂疾病。

Global Peptide Market Growth Signals Massive Opportunity

全球肽市场增长信号显示巨大机遇

The global peptide therapeutics market is experiencing explosive expansion. Estimates suggest it was valued between USD 110 billion and USD 150 billion in 2025, with projections indicating it could reach as high as USD 380 billion by 2035

全球多肽治疗市场正在经历爆炸式扩张。据估计，2025年其价值在1100亿美元至1500亿美元之间，预测表明到2035年可能高达3800亿美元。

This growth is fueled by increasing rates of chronic diseases such as obesity, diabetes, cardiovascular disorders, and cancer, alongside advancements in peptide synthesis, stabilization, and delivery systems.

这一增长是由慢性疾病（如肥胖症、糖尿病、心血管疾病和癌症）发病率的上升，以及肽合成、稳定和递送系统的进步所推动的。

What makes peptides particularly attractive is their hybrid nature. They combine the potency and specificity of biologics with the manufacturability of small molecules. This has led to faster development timelines and reduced production costs compared to monoclonal antibodies or other drugs. Pharmaceutical companies are now heavily investing in peptide platforms, including oral peptide formulations that overcome the need for injections and multi-functional peptides capable of targeting multiple biological pathways simultaneously..

使肽特别具有吸引力的是它们的混合性质。它们结合了生物制剂的效力和特异性以及小分子的可制造性。与单克隆抗体或其他药物相比，这导致了更快的开发时间和更低的生产成本。制药公司现在正在大力投资于肽平台，包括克服注射需求的口服肽制剂以及能够同时靶向多个生物途径的多功能肽。

Expanding Clinical Applications Across Multiple Fields

扩展多个领域的临床应用

The real-world applications of peptides are both diverse and transformative. In metabolic medicine, GLP-1 receptor agonists such as semaglutide and tirzepatide have revolutionized the treatment of obesity and type 2 diabetes. These peptides mimic natural gut hormones to regulate appetite, enhance insulin sensitivity, and promote significant weight loss.

肽在现实世界中的应用既多样化又具有变革性。在代谢医学领域，像司美格鲁肽和替西帕肽这样的GLP-1受体激动剂已经彻底改变了肥胖症和2型糖尿病的治疗方法。这些肽模拟天然肠道激素来调节食欲、增强胰岛素敏感性并促进显著减重。

Patients using these therapies often experience reductions of up to 20 percent of body weight, along with improved cardiovascular outcomes..

使用这些疗法的患者通常会减重高达体重的20%，同时心血管健康状况也有所改善。

These semaglutides have also been found to aid in the prevention and treatment of other diseases as well.

这些司美格鲁肽还被发现有助于预防和治疗其他疾病。

In bone health, teriparatide has emerged as a powerful anabolic agent for osteoporosis. By stimulating new bone formation, it significantly reduces fracture risk, particularly in postmenopausal women and elderly patients. This represents a shi

在骨骼健康方面，特立帕肽已成为治疗骨质疏松症的一种强效合成代谢药物。通过刺激新骨形成，它显著降低了骨折风险，特别是在绝经后女性和老年患者中。这代表了一种转变。

ft from traditional treatments that only slow bone loss rather than actively rebuilding bone density.

传统治疗只能减缓骨质流失，而不能积极重建骨密度。

Oncology is another area where peptides are making a profound impact. Peptide-based therapies can act as targeted drug delivery systems, directing chemotherapeutic agents precisely to tumor cells while sparing healthy tissue.

肿瘤学是肽正在产生深远影响的另一个领域。基于肽的疗法可以作为靶向药物递送系统，将化疗药物精确地导向肿瘤细胞，同时避开健康组织。

Additionally, certain peptides function as direct anti-tumor agents or immune modulators, enhancing the body’s natural defenses against cancer.

此外，某些肽类作为直接的抗肿瘤剂或免疫调节剂，增强身体对癌症的自然防御能力。

Regenerative Medicine and Performance Recovery Applications

再生医学与性能恢复应用

One of the most exciting areas of peptide innovation lies in regenerative medicine. Compounds such as BPC-157 have demonstrated remarkable healing properties. Derived from a protective protein found in the stomach, BPC-157 promotes angiogenesis, accelerates tissue repair, and reduces inflammation. It has shown promise in treating tendon injuries, ligament damage, and gastrointestinal disorders..

再生医学是肽创新最令人兴奋的领域之一。像BPC-157这样的化合物已经展示了显著的愈合特性。BPC-157源于胃部发现的一种保护性蛋白，它促进血管生成、加速组织修复并减少炎症。在治疗肌腱损伤、韧带损伤和胃肠道疾病方面已显示出希望。

Similarly, TB-500, a synthetic version of thymosin beta-4, enhances cellular migration and tissue regeneration. It is widely studied for its ability to accelerate wound healing and improve recovery from musculoskeletal injuries. Athletes and patients recovering from surgery or chronic injuries are increasingly turning to such peptides for faster rehabilitation..

同样，TB-500（胸腺素β4的合成版本）可增强细胞迁移和组织再生。它因加速伤口愈合和改善肌肉骨骼损伤恢复的能力而受到广泛研究。运动员以及从手术或慢性损伤中康复的患者越来越多地转向此类肽类以实现更快的康复。

Growth hormone secretagogues like CJC-1295 and Ipamorelin represent another major category. These peptides stimulate the body’s natural production of growth hormone without the risks associated with synthetic hormone replacement. Benefits include improved muscle mass, enhanced recovery, better sleep quality, and potential anti-aging effects.

像CJC-1295和Ipamorelin这样的生长激素促分泌剂代表了另一主要类别。这些肽类能够刺激身体自然产生生长激素，而无需承担与合成激素替代相关的风险。其益处包括增加肌肉质量、加速恢复、改善睡眠质量以及潜在的抗衰老效果。

These therapies are gaining traction in wellness clinics worldwide..

这些疗法正在全球各地的健康诊所中逐渐受到关注。

Gastrointestinal And Infectious Disease Breakthroughs

胃肠病与传染病的突破性进展

Peptides are also transforming gastrointestinal medicine. Linaclotide, for instance, is used to treat irritable bowel syndrome with constipation by activating specific receptors in the gut to increase fluid secretion and improve bowel movements. Its targeted mechanism reduces systemic side effects, making it a preferred option for many patients..

肽类药物也正在改变胃肠病学。例如，利那洛肽通过激活肠道中的特定受体来增加液体分泌并改善肠蠕动，用于治疗便秘型肠易激综合征。其靶向机制减少了全身性副作用，成为许多患者的首选方案。

In infectious diseases, peptides like enfuvirtide have played a critical role in HIV treatment by preventing viral entry into host cells. Researchers are now exploring antimicrobial peptides that could combat antibiotic-resistant bacteria, a growing global health threat. These peptides work by disrupting microbial membranes, offering a novel approach to infection control..

在传染病领域，像恩夫韦肽这样的肽类通过阻止病毒进入宿主细胞，在艾滋病治疗中发挥了关键作用。研究人员现在正在探索可能对抗抗生素耐药菌的抗菌肽，这是一种日益严重的全球健康威胁。这些肽通过破坏微生物膜，为感染控制提供了新的途径。

Neurological And Immunological Frontiers

神经学与免疫学前沿

Emerging research is uncovering the potential of peptides in neurological and autoimmune diseases. Certain neuroprotective peptides are being investigated for their ability to reduce inflammation and oxidative stress in conditions such as Alzheimer’s and Parkinson’s disease. Others are being designed to modulate immune responses, offering new treatment pathways for autoimmune disorders like rheumatoid arthritis and multiple sclerosis..

新兴研究表明，肽在神经和自身免疫疾病中具有潜在作用。某些神经保护肽正被研究其在减少阿尔茨海默病和帕金森病等疾病中的炎症和氧化应激方面的能力。其他肽则被设计用于调节免疫反应，为类风湿性关节炎和多发性硬化症等自身免疫疾病提供了新的治疗途径。

This

这

Thailand Medical

泰国医学

News report highlights that peptides are not merely incremental improvements but represent a paradigm shift in how diseases are treated and managed. Their ability to precisely interact with biological systems opens doors to personalized medicine approaches that were previously unattainable.

新闻报道强调，肽类不仅仅是渐进式的改进，而是代表了疾病治疗和管理方式的范式转变。它们能够与生物系统精确互动，为以前无法实现的个性化医疗方法打开了大门。

Thailand Strategic Position in Global Peptide Innovation

泰国在全球肽创新中的战略地位

Thailand already holds a strong position in global healthcare due to its advanced medical infrastructure and thriving medical tourism industry. With more than 62 internationally accredited hospitals and significantly lower treatment costs compared to Western countries, the nation attracts millions of patients annually..

由于先进的医疗基础设施和蓬勃发展的医疗旅游产业，泰国在全球医疗领域已经占据强势地位。该国拥有62家国际认证的医院，且治疗费用较西方国家显著低廉，每年吸引数百万患者前来就诊。

Cities such as Bangkok, Phuket, and Pattaya have become hubs for advanced medical and wellness treatments, including peptide therapies administered under licensed physicians. The country’s regulatory framework, while maintaining safety standards, is more flexible than many Western systems where numerous peptides remain restricted to research use..

诸如曼谷、普吉岛和芭提雅等城市已经成为先进医疗和健康治疗的中心，包括由持牌医生进行的肽类疗法。该国的监管框架在保持安全标准的同时，比许多西方国家的体系更为灵活，在那些西方国家，众多肽类物质仍然仅限于研究使用。

Government initiatives such as the Bio-Circular-Green economic model and investment incentives from the Board of Investment have further strengthened Thailand’s biopharmaceutical sector. Facilities dedicated to biologics and advanced therapeutics are already operational, providing a strong foundation for peptide expansion..

政府推出的生物循环绿色经济模式以及投资促进委员会的投资激励措施进一步加强了泰国的生物制药行业。致力于生物制品和先进治疗的设施已经投入运营，为肽类扩展提供了坚实的基础。

Urgent Need for Dedicated Peptide Research Expansion

迫切需要扩大专注的肽研究

To fully capitalize on this opportunity, Thailand must significantly scale up its peptide research capabilities. Establishing specialized research centers focused exclusively on peptide science would accelerate innovation. Collaborations between universities, hospitals, and private biotech firms could drive the development of new therapies tailored to regional health challenges..

为了充分利用这一机会，泰国必须大幅提高其肽研究能力。建立专注于肽科学的专门研究中心将加速创新。大学、医院和私人生物技术公司之间的合作可以推动针对区域健康挑战的新疗法开发。

Research efforts should prioritize areas such as improved peptide stability, oral delivery systems, and cost-effective manufacturing techniques. Clinical trials focused on Southeast Asian populations would also provide valuable data, ensuring therapies are optimized for local demographics.

研究工作应优先考虑改进肽稳定性、口服递送系统和具有成本效益的制造技术等领域。专注于东南亚人群的临床试验也将提供宝贵的数据，确保治疗方法针对当地人口群体进行优化。

Public and private investment will be crucial in this regard. Funding mechanisms that support early-stage research and commercialization can help transform scientific discoveries into market-ready treatments. This would not only enhance healthcare outcomes but also generate intellectual property and export revenue..

公共和私人投资在这方面将至关重要。支持早期研究和商业化的资金机制有助于将科学发现转化为市场可用的治疗方法。这不仅会改善医疗保健结果，还会产生知识产权和出口收入。

Strengthening Physician Training Through CME Programs

通过继续医学教育项目加强医生培训

Another critical step is the expansion of specialized Continuing Medical Education programs focused on peptide therapies. Physicians must be equipped with in-depth knowledge of peptide pharmacology, dosing strategies, patient selection, and risk management.

另一个关键步骤是扩展专注于肽疗法的专业继续医学教育计划。医生必须掌握肽药理学、剂量策略、患者选择和风险管理的深入知识。

Standardized training programs can ensure consistent clinical practices across the country. By integrating peptide education into medical curricula and professional development courses, Thailand can build a highly skilled workforce capable of delivering world-class care.

标准化的培训计划可以确保全国范围内临床实践的一致性。通过将肽类教育整合到医学课程和专业发展课程中，泰国能够培养一支高技能的医疗队伍，提供世界级的医疗服务。

Such initiatives would also enhance patient trust and position Thai practitioners as global leaders in peptide medicine. As demand for these therapies grows, having a well-trained medical community will be a key differentiator.

此类举措还将增强患者信任，并使泰国从业者成为肽类药物领域的全球领导者。随着这些疗法需求的增长，拥有一个训练有素的医学界将成为关键的差异化因素。

Regulatory Evolution to Unlock Clinical Potential

解锁临床潜力的监管演变

Regulatory reform will play a pivotal role in enabling the growth of peptide therapies. While maintaining strict safety standards, Thailand can streamline approval processes for clinical use and research. Clear guidelines for compounding, prescribing, and monitoring peptides would reduce uncertainty and encourage innovation..

监管改革将对推动肽类疗法的发展起到关键作用。在保持严格安全标准的同时，泰国可以简化临床使用和研究的审批流程。针对多肽的配制、处方和监测制定明确的指导方针，将减少不确定性并鼓励创新。

Facilitating the importation of high-quality research peptides and accelerating approval timelines for new indications can significantly boost the industry. Implementing robust pharmacovigilance systems will ensure patient safety while allowing for broader access.

促进高质量研究肽的进口并加快新适应症的审批时间可以显著推动行业发展。实施强有力的药物警戒系统将确保患者安全，同时允许更广泛的获取。

Balanced regulatory adjustments can attract international patients who are unable to access these therapies in their home countries due to restrictive policies. This would further strengthen Thailand’s position as a leading destination for advanced medical treatments.

平衡的监管调整可以吸引因本国政策限制而无法获得这些治疗的国际患者，这将进一步巩固泰国作为先进医疗治疗首选目的地的地位。

Economic And Healthcare Impact of Peptide Expansion

肽扩展的经济与医疗影响

The economic benefits of investing in peptide research and clinical application are substantial. Thailand’s medical tourism industry is projected to reach USD 24 billion by 2027, and peptides could represent a high-value segment within this market.

投资于肽研究和临床应用的经济效益是巨大的。预计到2027年，泰国的医疗旅游业将达到2400亿美元，而肽可能成为该市场中的高价值细分领域。

Developing a strong peptide ecosystem would create high-skilled jobs, stimulate local manufacturing, and reduce reliance on imported pharmaceuticals. It would also enhance the country’s reputation as a hub for cutting-edge medical innovation.

发展强大的肽生态系统将创造高技能工作岗位、刺激本地制造业，并减少对进口药品的依赖。同时，这还将提升该国作为尖端医疗创新中心的声誉。

Patients would benefit from access to advanced therapies that improve quality of life and address conditions that are difficult to treat with conventional approaches. This aligns with broader healthcare goals of preventive medicine and personalized treatment.

患者将受益于能够改善生活质量和解决传统方法难以治疗的病症的先进疗法。这与预防医学和个性化治疗等更广泛的医疗目标相一致。

Peptide Manufacturing in Thailand

泰国的肽制造

China is currently the leading country that has advanced peptide manufacturing capabilities and technology and Thailand should invite relevant Chinese companies to co-invest into setting up such manufacturing plants in Thailand with the support from the Thai government.

中国是当前拥有先进肽制造能力和技术的领先国家，泰国应邀请相关中国企业，在泰国政府的支持下，共同投资在泰国设立此类制造厂。

Final Perspective on Thailand Peptide Future

泰国肽未来最终展望

Peptides are rapidly redefining the boundaries of modern medicine, offering targeted, efficient, and versatile solutions to some of the most pressing health challenges. Thailand possesses all the essential elements needed to lead this revolution, including advanced healthcare infrastructure, a strong medical tourism base, and supportive government policies.

肽正在迅速重新定义现代医学的边界，为一些最紧迫的健康挑战提供有针对性、高效且多样的解决方案。泰国拥有引领这场革命所需的所有关键要素，包括先进的医疗基础设施、强大的医疗旅游基础以及支持性的政府政策。

By significantly increasing investment in peptide research, expanding physician education through structured training programs, and implementing thoughtful regulatory reforms that ensure safety while improving access, the country can unlock immense medical and economic potential. Such strategic actions will not only elevate Thailand’s global standing in healthcare innovation but also provide patients with access to transformative therapies that improve outcomes and extend quality of life..

通过大幅增加对肽研究的投资、通过结构化培训项目扩展医生教育，以及实施周全的监管改革以确保安全并改善获取途径，该国可以释放巨大的医疗和经济潜力。这些战略举措不仅将提升泰国在全球医疗创新中的地位，还将为患者提供获得变革性治疗的机会，从而改善治疗效果并延长生活质量。

References:

参考文献：

https://thailandwellness.news/the-top-peptides-that-many-individuals-are-taking-in-the-current-wellness-biohacking-fad/

https://thailandwellness.news/当前健康生物黑客潮流中许多人正在使用的顶级肽/

https://thailandwellness.news/peptide-stacking-unlocks-the-next-level-of-wellness/

https://thailandwellness.news/peptide-stacking-unlocks-the-next-level-of-wellness/

For the latest on peptides, keep on logging to

有关肽的最新信息，请继续登录

Thailand Medical

泰国医学

News.

新闻。